FDA Inspection
Orient Pharma Co., Ltd. Yunlin PlantOrient Pharma Co., Ltd. Yunlin Plant – FDA Inspection, Nov 16, 2018
Record Details
This FDA Inspection record concerns Orient Pharma Co., Ltd. Yunlin Plant, with an inspection on November 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e457d267-6392-48cb-a24b-4e722690553b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1077757
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Orient Pharma Co., Ltd. Yunlin Plant
4| Date | Classification | Office | Project area |
|---|---|---|---|
| May 23, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 6, 2018 | Not classified | Office of Inspections and Investigations | |
| April 3, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 14, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Orient Pharma Co., Ltd. Yunlin Plant
- FDA Inspection 1274326 - 2025-05-23
- FDA Inspection 1062312 - 2018-07-06
- FDA Inspection 921908 - 2015-04-03
- FDA Inspection 813081 - 2012-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.